HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful treatment for ulcerative proctitis with rectal tacrolimus in an 8-year-old girl with intolerance to mesalamine.

Abstract
Ulcerative colitis (UC) is defined as a chronic inflammatory condition causing continuous mucosal inflammation of the colon without granulomas on biopsy. It affects the rectum, and, to a variable extent, the colon in continuity and is characterized by a relapsing and remitting course. Oral 5-aminosalicylic acid (5-ASA) regimens are recommended as first-line induction therapy for mild to moderately active pediatric UC and for maintenance of remission regardless of other initial treatments. In large clinical trials in adults, mesalamine intolerance was found in 2-5 % of the patients. We present a case of an 8-year-old female patient with intolerance to mesalamine and proctitis resistant to conventional therapy who responded to rectal tacrolimus treatment. The patient started with a dose of 2 mg/day at night with an excellent response. She reported feeling better than any of the previously prescribed treatments and without feeling the discomfort of previously administered enemas. After four weeks of treatment, the dose was reduced to 2 mg/week with no relapses. Tacrolimus suppositories were very well tolerated, and no adverse effects have been reported. Although only very little data has been published, rectal tacrolimus seems to be safe and of efficacy in ulcerative proctitis resistant to standard therapy.
AuthorsVíctor Manuel Navas-López, Javier Blasco-Alonso, Francisco Girón Fernández-Crehuet, Maria Juliana Serrano Nieto, Silvia Gallego-Gutiérrez, Silvia Luque Pérez, Carlos Sierra Salinas
JournalClinical journal of gastroenterology (Clin J Gastroenterol) Vol. 7 Issue 4 Pg. 320-3 (Aug 2014) ISSN: 1865-7265 [Electronic] Japan
PMID26185880 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Immunosuppressive Agents
  • Mesalamine
  • Tacrolimus
Topics
  • Administration, Rectal
  • Anti-Inflammatory Agents, Non-Steroidal (adverse effects)
  • Child
  • Colitis, Ulcerative (complications, drug therapy)
  • Female
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Mesalamine (adverse effects)
  • Proctitis (drug therapy, etiology)
  • Remission Induction
  • Tacrolimus (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: